Centrovet, a aquaculture and animal health sectors company, completed the acquisition of the remaining 34% stake in Virbac, a sixth-largest animal health global company, for $47m. "With this acquisition, we are consolidating our position in this promising market and strategic aquaculture segment for our Group (Chile being the world's second largest producer of salmon). Centrovet, thanks to its industrial footprint and R&D infrastructures, gives us a real competitive advantage in the Chilean aquaculture industry. With a highly engaged team, we have the ambition to further bring innovative products and solutions to the local market and to search for additional synergies on the R&D and manufacturing sides between the cold and warm-water fish segments," Sébastien Huron, Virbac CEO.